2-Bromo-1-(5-chloropyridin-2-yl)ethanone

Catalog No.: 
ACIHZR283
CAS No.: 
94952-47-3
Molecular Formula: 
C7H5BrClNO
Molecular Weight: 
234.48
2-Bromo-1-(5-chloropyridin-2-yl)ethanone structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg98%
1g98%
5g98%
25g98%

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-Bromo-1-(5-chloropyridin-2-yl)ethanone
IUPAC Name2-bromo-1-(5-chloropyridin-2-yl)ethan-1-one
MDL No.MFCD10697657
Molecular FormulaC7H5BrClNO
Molecular Weight234.48
SMILESClC1=CN=C(C=C1)C(=O)CBr
InChI KeyLAZQJVLXFVZZCY-UHFFFAOYSA-N
Synonym2-Bromo-1-(5-chloropyridin-2-yl)ethan-1-one
CAS No.94952-47-3
PubChem CID11183925

Safety Data

Pictogram
CorrosiveHarmful or irritant
Signal Word
Gefahr
Hazard Statement(s)
H302-H315-H318-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P310-P330-P332+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACIHZR283 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACMOZX619 route compound structure diagram
    ACMOZX61940473-01-6In Stock
  4. Then
  5. ACIHZR283 route product structure diagram
    ACIHZR28394952-47-3In Stock
Inquiry

2. ACIHZR283 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACAJSL531 route compound structure diagram
    ACAJSL53194952-46-2In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACIHZR283 route product structure diagram
    ACIHZR28394952-47-3In Stock
Inquiry

3. ACIHZR283 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACIHZR283 route product structure diagram
    ACIHZR28394952-47-3In Stock
Inquiry

Comments (0)